CAS: 27523-40-6; 1-[2-(2,4-Dichlorophenyl)-2-[(2,6-Dichlorophenyl)Methoxy]Ethyl]Imidazole

该化合物是一种属于Inidazole化合物类的抗冻剂,主要用于农业用途,以控制作物中的真菌疾病;它展示了各种抗菌活动,包括植物病原体的病原体;Isoconazole功能,抑制了生菌细胞膜的基本成分ERgosterol的合成,从而破坏其完整性和功能;该化合物通常作为一种系统杀真菌剂使用,允许植物吸收,并保护其不受体内影响;从物理特性来看,异氯氮诺醇通常以水溶性低为特征,但有机溶剂的溶性较高为特征,有助于其制剂的应用;重要的是要谨慎地处理异氯硝醇,因为如果不按照安全准则使用,它可能会对人类健康和环境造成危险;

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号2631-72-3 2-溴-2',4'-二氯苯乙酮 | CAS号4252-78-2 2,2',4'-三氯苯乙酮 | CAS号46503-52-0 2'-(1H-咪唑-1-基)-... | CAS号13692-14-3 Alpha-(氯甲基)-2,4... | CAS号24155-42-8 1-(2,4-二氯苯基)-2-... | CAS号2014-83-7 2,6-二氯氯苄

合成工艺路线路线简述

  • 合成目标产物 Isoconazole 主要起始原料 Alpha-(2,4-Dichlorophenyl)-1H-Imidazole-1-Ethanol
  • (文献来源)合成步骤主要原料 Alpha-(2,4-Dichlorophenyl)-1H-Imidazole-1-Ethanol
2,2',4'-三氯苯乙酮置于sodium Tetrahydroborate,Sodium Hydride体系中,用 1,4-二氧六环,异丙醇,乙腈,Mineral Oil 用作溶剂,化学反应 3.0H,反应生成异康唑
参考文献:New Copper(II) Complexes With Isoconazole: Synthesis,Structures And Biological Properties
标题:New Copper(II) Complexes With Isoconazole: Synthesis,Structures And Biological Properties
摘要:There Is An Increasing Demand For Novel Metal-Based Complexes With Biologically Relevant Molecules In Technology And Medicine. Three New Cu(II) Coordination Compounds With Antifungal Agent Isoconazole (L),Namely Mononuclear Complexes [cucl2(L)(2)] (1),And [cu(O2Cme)(2)(L)(2)]Center Dot 2H(2)O (2) And Coordination Polymer [cu(Pht)(L)(2)](N) (3) (Where H(2)Pht-O-Phthalic Acid) Were Synthesized And Characterized By Ir Spectroscopy,Thermogravimetric Analysis And X-Ray Crystallography. X-Ray Analysis Showed That In All Complexes,The Isoconazole Is Coordinated To Cu(II) Centres By A N Atom Of The Imidazole Fragment. In Complex I,The Square-Planar Environment Of Cu(II) Atoms Is Completed By Two N Atoms Of Isoconazole And Two Chloride Ligands,Whereas The Cu(II) Atoms Are Coordinated By Two N Atoms From Two Isoconazole Ligands And Two O Atoms From The Different Carboxylate Residues: Acetate In 2 And Phthalate In 3. The Formation Of An Infinite Chain Through The Bridging Phthalate Ligand Is Observed In 3. The Biosynthetic Ability Of Micromycetes Aspergillus Niger Cnmn Fd 10 In The Presence Of The Prepared Complexes 1-3 As Well As The Antifungal Drug Isoconazole Were Studied. Complexes 2 And 3 Accelerate The Biosynthesis Of Enzymes (Beta-Glucosidase,Xylanase And Endoglucanase) By This Fungus. Moreover,A Simplified And Improved Method For The Preparation Of Isoconazole Nitrate Was Developed. (C) 2012 Elsevier Ltd. All Rights Reserved.
Doi:10.1016/j.Poly.2012.10.040

海关参考信息

专利信息


专利号:US-10925977-B2
优先权日:2006-10-05
标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

专利号:WO-2025085030-A1
优先权日:2023-10-18
标 题:Synthesis of semisynthetic penicillin derivatives containing hydrazone-derived thiazolidine and imidazole ring
发明人:SARIPINAR EMIN; BURAN SUMEYYE
权利人:ERCIYES UNIV
摘要:The present invention relates to the novel semi-synthetic thiazolidine and imidazole penicillin, pharmaceutically acceptable derivatives thereof and their synthesis method that may cause biologically significant changes by the N-acylation reaction of 6-aminopenicillanic (6-APA) using new trisubstituted thiazolidine and imidazole acetyl chloride derivatives. The invention also relates to pharmaceutical compositions comprising these compounds and their use for therapeutic treatment in the human or animal body.

专利号:WO-2025085026-A1
优先权日:2023-10-18
标 题:Synthesis of semisynthetic penicillin derivatives containing hydrazone-derived thiazolidine and imidazole ring
发明人:SARIPINAR EMIN; BURAN SUMEYYE
权利人:T C ERCIYES UNIV
摘要:The present invention relates to the novel semi-synthetic thiazolidine and imidazole penicillin, pharmaceutically acceptable derivatives thereof and their synthesis method that may cause biologically significant changes by the N-acylation reaction of 6-aminopenicillanic (6-APA) using new trisubstituted thiazolidine and imidazole acetyl chloride derivatives. The invention also relates to pharmaceutical compositions comprising these compounds and their use for therapeutic treatment in the human or animal body.

专利号:US-2024336559-A1
优先权日:2021-10-06
标 题 :Anti-fungals compounds targeting the synthesis of fungal sphingolipids
发明人:OJIMA IWAO; HARANAHALLI KRUPANANDAN; DEL POETA MAURIZIO; GARG ASHNA
权利人:UNIV NEW YORK STATE RES FOUND
摘要:The present invention provides a compound having the structure: n n n n n n n n n n n n wherein n R 3 , R 4 , R 5 , R 6 , and R 7 are each independently, H, halogen, CN, —CF 3 , —OCF 3 , —NO 2 , alkyl, alkenyl, alkynyl, aryl, heteroaryl, heterocycle, —OH, —OAc, —OR 13 , —COR 13 , —CH 2 OR 13 , —SH, —SR 13 , —SO 2 R 13 , —NH 2 , —NHR 13 , —NR 14 R 15 , —NHCOR 12 , or —CONR 14 R 15 ; n R 9 , R 10 , R 11 , and R 12 are each independently, H, CN, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, —OAc, —COR 13 , —SH, —SR 13 , —SO 2 R 13 , —NH 2 , —NHR 13 , —NR 14 R 15 , —NHCOR 12 , or —CONR 14 R 15 ;n wherein each occurrence of R 13 is independently alkyl, alkenyl, alkynyl, aryl, or heteroaryl, wherein each occurrence of R 14 is independently —H, alkyl, alkenyl, alkynyl, aryl, or heteroaryl, wherein each occurrence of R 15 is independently —H, alkyl, alkenyl, alkynyl, aryl, or heteroaryl, n n wherein when R 14 is methyl, R 15 is not methyl; n wherein at least one of R 9 , R 10 , R 11 , and R 12 is not H; n wherein at least one of R 3 , R 4 , R 5 , R 6 , and R 7 is not H.

专利号:US-9382288-B2
优先权日:2010-10-06
标题 :Derivatives of steroid benzylamines, having an antiparasitic antibacterial, antimycotic and/or antiviral action
发明人:BECKER KATJA; KRIEG REIMAR; SCHÖNECKER BRUNO
权利人:BECKER KATJA; KRIEG REIMAR; SCHÖNECKER BRUNO; UNIV GIESSEN JUSTUS LIEBIG
摘要:The present invention relates to compounds derived from steroids of the general formula (I) n nwherein L represents a linker and R # represents a steroid residue, the use of compounds of the general formula (I) in medicine and for the prophylaxis and/or the treatment of infectious diseases. Furthermore described are pharmaceutical compositions containing at least one compound of the general formula (I). A further aspect of the invention relates to the synthesis of said compounds of the general formula (I).

专利号:US-10443047-B2
优先权日:2014-05-01
标题 :Increasing cellular lipid production by increasing the activity of diacylglycerol acyltransferase and decreasing the activity of triacylglycerol lipase
发明人:TSAKRAKLIDES VASILIKI; BREVNOVA ELENA E
权利人:NOVOGY INC
摘要:Disclosed are methods and compositions for increasing the triacylglycerol content of a cell by up-regulating diacylglycerol acyltransferase and down-regulating triacylglycerol lipase. In some embodiments, a DGA1 protein is expressed and a native TGL3 gene is knocked out, thereby increasing the synthesis of triacylglycerol and decreasing its consumption, respectively.
池州中瑞化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.zhongruichem.com
电话: 0566-8178912👤
📞池州中瑞化工有限公司 ⚠️参考联系方式

销售电话:0566-8178912
邮箱:sales@zhongruichem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

东至县香隅化工园区
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
摘要:S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (2021) DOI:10.1021/acsenvironau.1c00008. List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知